Results 111 to 120 of about 4,207 (149)

[EEFSEC knockdown inhibits proliferation, migration and invasion of prostate cancer cells in vitro]. [PDF]

open access: yesNan Fang Yi Ke Da Xue Xue Bao, 2021
Xu B   +9 more
europepmc   +1 more source

前列腺特异性膜抗原PET/CT对减少前列腺癌过度穿刺活检的应用价值

open access: yesZhongshan Daxue xuebao. Yixue kexue ban
目的评估前列腺特异性膜抗原(PSMA)PET/CT在前列腺穿刺活检筛查中的应用效果,提出基于PSMA PET/CT检查的前列腺癌穿刺活检策略。方法回顾性分析2020年1月至2023年12月期间155例可疑前列腺癌患者穿刺活检前的PSMA PET/CT图像和临床病理资料。采用PRIMARY 评分作为PSMA PET/CT诊断前列腺癌的标准化评估方法,比较不同PRIMARY 评分筛选前列腺穿刺患者的活检阳性率、漏诊患者比例及避免活检患者比例。使用ROC曲线分析PSA及其衍生指标 ...
张继燊   +4 more
doaj  

[Bipolar androgen therapy followed by immune checkpoint inhibitors in metastatic castration resistant prostate cancer: A report of 4 cases]. [PDF]

open access: yesBeijing Da Xue Xue Bao Yi Xue Ban, 2022
Liu SJ   +6 more
europepmc   +1 more source

[Multi-omics analysis of the relationship between oxidative stress-related gene and prostate cancer]. [PDF]

open access: yesBeijing Da Xue Xue Bao Yi Xue Ban
Ning J   +6 more
europepmc   +1 more source

[Evaluating continence recovery time after robot-assisted radical prostatectomy]. [PDF]

open access: yesBeijing Da Xue Xue Bao Yi Xue Ban, 2021
Hao H   +15 more
europepmc   +1 more source

前列腺癌患者3年生存的预测因素分析

open access: yesZhongshan Daxue xuebao. Yixue kexue ban, 2016
摘 要: 【目的】 分析前列腺癌病人的多种临床指标与其3年生存的相关性,为前列腺癌病人预后判断提供依据?【方法】 回顾性随访分析341名前列腺癌病人的资料,计算3年总生存率,并应用单因素相关分析及多因素logistic回归分析年龄(AGE)?总前列腺特异性抗原(TPSA)?直肠指检(DRE)?经直肠B超结果(TRUS)?前列腺特异性抗原密度(PSAD)?前列腺移行区体积密度(PSATZ)?肿瘤T2分期,转移情况?Gleason 评分?是否接受治疗等指标与病人3年生存的相关性 ...
doaj  

Home - About - Disclaimer - Privacy